Implantable drug delivery systems, assemblies, and methods

ABSTRACT

A connection assembly for an implantable drug delivery system includes a base member configured to be attached to a skull of a recipient and a manifold. The base member includes an access hole for accessing a burr hole in the skull of the recipient and an outer guide channel that extends along an outside edge of the base member. The manifold is configured to fluidically couple a proximal end portion of a microcatheter to a distal end portion of a source catheter. The base member is configured to position the microcatheter through the access hole and in the outer guide channel when a distal end portion of the microcatheter is implanted in a brain of the recipient.

RELATED APPLICATIONS

The present application is a continuation of U.S. patent applicationSer. No. 17/842,386, filed Jun. 16, 2022, which claims priority under 35U.S.C. § 119(e) to U.S. Provisional Patent Application No. 63/219,744,filed on Jul. 8, 2021, which is incorporated herein by reference in itsentirety.

BACKGROUND INFORMATION

Some people suffering from neurological disorders and other conditionsmay be treated with drugs, such as neurotherapeutic drugs. The drugs areoften administered to the recipient intravenously, but intravenousadministration often has drawbacks. For example, the blood-brain barriermay prevent effective transport of neurotherapeutic drugs to a targetlocation in brain tissue. Additionally, intravenous administration ofdrugs may cause various systemic side effects for a recipient, such asin the cardiovascular system and/or the gastrointestinal system.Accordingly, there is a need for more effective systems and methods ofdelivering drugs to a target location within a body of a recipient withfewer side effects for the recipient.

BRIEF DESCRIPTION OF THE DRAWINGS

The accompanying drawings illustrate various embodiments and are a partof the specification. The illustrated embodiments are merely examplesand do not limit the scope of the disclosure. Throughout the drawings,identical or similar reference numbers designate identical or similarelements.

FIG. 1 shows a functional diagram of an illustrative implantable drugdelivery system.

FIG. 2 shows a cross-sectional view of a distal end portion of anillustrative implementation of a microcatheter included in theimplantable drug delivery system of FIG. 1 .

FIG. 3 shows the cross-sectional view of the distal end portion of themicrocatheter of FIG. 2 when fluid from a fluid source is pushed throughthe microcatheter.

FIG. 4 shows a cross-sectional view of a distal end portion of anotherillustrative implementation of the microcatheter included in theimplantable drug delivery system of FIG. 1 .

FIG. 5A shows an illustrative implementation of a source catheterincluded in the implantable drug delivery system of FIG. 1 .

FIG. 5B shows a cross-sectional view of the source catheter of FIG. 5A.

FIG. 6A shows a top view of an illustrative cranial port that mayimplement a connection assembly included in the implantable drugdelivery system of FIG. 1 .

FIG. 6B shows a side view of the cranial port of FIG. 6A.

FIG. 7 shows a top view of the cranial port of FIGS. 6A and 6B when aproximal end portion of a microcatheter and a distal end portion of asource catheter are connected by way of a manifold in the cranial port.

FIG. 8A shows a cross-sectional side view of a microcatheter and anillustrative implementation of a connector for the microcatheter in anunassembled state.

FIG. 8B shows a cross-sectional side view of the connector andmicrocatheter of FIG. 8A in an assembled state.

FIG. 9A shows a top view of another illustrative implementation of acranial port that may implement the connection assembly included in theimplantable drug delivery system of FIG. 1 .

FIG. 9B shows a top view of a cover configured to cover the cranial portof FIGS. 6A, 6B, 7, and 9A.

FIG. 10A shows a cross-sectional view of an illustrative implementationof a coupling that may implement the connection assembly included in theimplantable drug delivery system of FIG. 1 .

FIG. 10B shows a cross-sectional view of the coupling of FIG. 10A in anassembled state connected to a microcatheter and a source catheter.

FIG. 11A shows a top view of an illustrative implementation of a fillport that may implement a fluid source included in the implantable drugdelivery system of FIG. 1 .

FIG. 11B shows a cross-sectional side view of the fill port of FIG. 11A.

FIG. 12 shows a cross-sectional side view of the fill port of FIGS. 11Aand 11B in an assembled state connected to a source catheter.

FIG. 13 shows a functional diagram of another illustrative implantabledrug delivery system including an external pump.

FIG. 14 shows a functional diagram of another illustrative implantabledrug delivery system including an implantable pump.

FIG. 15A shows a functional diagram of an illustrative implementation ofan internal alignment circuit that may be included in a fluid source andan external alignment circuit that may be included in an externaldevice.

FIG. 15B shows an illustrative implementation of the fill port of FIGS.11A-12 including the internal alignment circuit and in which an internalconductive coil is positioned around the chamber of the fill port.

FIG. 16 shows another illustrative implementation of the fill port ofFIGS. 11A-12 including the internal alignment circuit of FIG. 15A and inwhich a plurality of internal conductive coils are positioned withinside walls of the fill port.

FIG. 17A shows a side view of an illustrative implementation of a duallumen catheter that may implement the microcatheter of the drug deliverysystem of FIG. 1 .

FIG. 17B shows a cross-sectional view of the dual lumen catheter of FIG.17B.

DETAILED DESCRIPTION

Implantable drug delivery systems, assemblies, and methods are describedherein. For example, an illustrative implantable drug delivery systemmay include a connection assembly, a source catheter, and amicrocatheter. A proximal end portion of the source catheter may beconfigured to be fluidically connected to a fluid source configured toprovide a fluid (e.g., a neurotherapeutic drug). A distal end portion ofthe source catheter may be configured to be fluidically connected to theconnection assembly. The microcatheter may include a proximal endportion configured to be fluidically connected to the connectionassembly. A distal end portion of the microcatheter may include anelution opening configured to elute the fluid to a target location(e.g., a brain) within a recipient. As described herein, the fluidsource may be configured to provide the fluid to the target location byway of the source catheter, the microcatheter, and the connectionassembly, which fluidically connects the source catheter to themicrocatheter.

As used herein, the source catheter and the microcatheter may be“fluidically connected” one to another by being coupled such that fluidmay flow from the source catheter to the microcatheter. For example, anillustrative connection assembly may comprise a cranial port thatincludes a base member configured to be attached to a skull of therecipient and a manifold on the base member. The proximal end portion ofthe microcatheter and the distal end portion of the source catheter maybe connected to the manifold. Thus, the fluid source and sourcecatheter, which may be physically dissimilar (e.g., in shape,robustness, stiffness, etc.) from the microcatheter, may be fluidicallyconnected to the microcatheter through the manifold of the cranial port.

Because the cranial port is anchored to the skull and the sourcecatheter and the microcatheter are fluidically connected through thecranial port, mechanical forces that might act on the microcatheter arereduced or prevented. Thus, the cranial port helps secure the positionof the implanted microcatheter at the target location and preventsdislocation of the implanted distal end of the microcatheter.

Various embodiments of implantable drug delivery systems, assemblies,and methods will now be described in more detail with reference to thefigures.

FIG. 1 shows a functional diagram of an illustrative implantable drugdelivery system 100 (“system 100”). FIG. 1 shows system 100 in anassembled state, such as after system 100 has been implanted in arecipient. However, system 100 may also be in an unassembled state, suchas prior to implantation in the recipient. While in the unassembledstate, one or more components of system 100 may be unconnected fromother components of the system.

As shown in FIG. 1 , system 100 includes a microcatheter 102, a sourcecatheter 104, a connection assembly 106 (e.g., a cranial port) forfluidically connecting microcatheter 102 and source catheter 104, and afluid source 108 (e.g., a fill port) configured to provide a fluid. Thefluid may include, for example, a drug (e.g., a neurotherapeutic drug),a rinse (e.g., a saline solution), water, or any other fluid. System 100may also include additional or alternative components (not shown) as mayserve a particular implementation (e.g., bone screws, a pump, a syringe,a non-coring needle, etc.).

A distal end portion of microcatheter 102 is configured to be implantedat a target location 110 within the recipient. As used herein, a“recipient” may include a body of a live human or animal, a human oranimal cadaver, a portion of human or animal anatomy, tissue removedfrom human or animal anatomies, non-tissue work pieces, a trainingmodel, a dummy, etc. In some examples, target location 110 is a brain ofthe recipient and the fluid includes a neurotherapeutic drug. Forexample, the distal end portion of microcatheter 102 may be implanted inparenchymal tissue (e.g., nervous tissue) of the brain to deliver theneurotherapeutic drug directly to the parenchymal tissue, therebybypassing the blood-brain barrier and the cardiovascular system. Any oneor more additional components of system 100 may also be implantable inthe recipient. For example, connection assembly 106 may be implantableon a skull of the recipient, fluid source 108 may be implantable in thethorax of the recipient, and/or source catheter 104 may be implantablein the recipient extending from the thorax to the skull. System 100 isconfigured to deliver the fluid from fluid source 108 to target location110 through source catheter 104, connection assembly 106, andmicrocatheter 102, as indicated by arrows 112.

As used herein, “distal” means located away from fluid source 108 in adirection of fluid flow through system 100 (as indicated by arrows 112),and “proximal” means located nearer fluid source 108. For example, asshown in FIG. 1 a distal end portion of microcatheter 102 is implantableat target location 110 and a proximal end portion of microcatheter 102is connected to connection assembly 106. Additionally, a distal endportion of source catheter 104 is connected to connection assembly 106and a proximal end portion of source catheter 104 is connected to fluidsource 108.

Illustrative embodiments of microcatheter 102, source catheter 104,connection assembly 106, and fluid source 108 will now be described.

Microcatheter 102 includes a flexible, hollow tube configured to beimplanted at target location 110 to deliver the fluid to tissue attarget location 110. Microcatheter 102 may be formed of any suitablematerial, such as polyurethane, silicone, and/or any other biocompatiblematerial. Microcatheter 102 may be soft and flexible to prevent injuryto surrounding tissue and to facilitate implantation at target location110. In some examples, the hardness of microcatheter 102 is about 70Shore A durometer or less. In further examples, the hardness ofmicrocatheter 102 is between about 20 Shore A and about 60 Shore Adurometer. In yet further examples, the hardness of microcatheter 102 isbetween about 30 Shore A and about 50 Shore A durometer. In someexamples, such as when target location 110 is in the brain,microcatheter 102 is softer than the surrounding tissue to preventinjury to the surrounding tissue.

The hardness and flexibility of microcatheter 102 may also depend on thewall thickness of microcatheter 102. In some examples, the wallthickness of microcatheter 102 is between about 0.05 mm and about 0.15mm. In other examples, the wall thickness of microcatheter 102 isbetween about 5% and about 30% of the outer diameter of microcatheter102. In yet further examples, the wall thickness of microcatheter 102 isbetween about 7% and about 20% of the outer diameter of microcatheter102. In other examples, the wall thickness of microcatheter 102 isbetween about 10% and about 15% of the outer diameter of microcatheter102.

Microcatheter 102 may have any suitable outer diameter and/or innerdiameter as may serve a particular implementation. In some examples, theouter diameter of microcatheter 102 is about 1.0 millimeter (mm) orless. In further examples, the outer diameter of microcatheter 102 isbetween about 0.50 mm and about 1.0 mm. In some examples, the innerdiameter of microcatheter 102 is between about 0.30 mm and about 0.80mm. Generally, the length of microcatheter 102 depends on where thedistal end portion will be implanted (e.g., the implantation depth inbrain tissue, the thickness of the skull, etc.) and the distance fromtarget location 110 to connection assembly 106. Accordingly,microcatheter 102 may be cut to a desired length during implantation.

Microcatheter 102 includes an elution opening through which the drugelutes from microcatheter 102. In some embodiments, the elution openingmay be a distal tip of microcatheter 102. To prevent the buildup ofprotein and other particles in microcatheter 102 caused by the backflowof ambient fluid (e.g., cerebrospinal fluid (CSF)) into microcatheter102 through the elution opening, the distal tip may include a one-wayvalve, such as a duckbill valve. However, forming a duckbill valve atthe distal tip may be difficult with the small dimensions ofmicrocatheter 102. Accordingly, in other embodiments the elution openingis provided on a side wall of microcatheter 102, and a one-way valve isprovided over the elution opening, as will now be described withreference to FIG. 2 .

FIG. 2 shows a cross-sectional view of a distal end portion 202 of anillustrative implementation of microcatheter 102. As shown in FIG. 2 , ahole 204 is formed in a side wall 206 of distal end portion 202 ofmicrocatheter 102. Hole 204 may have any suitable size and shape. Insome examples, hole 204 has a diameter or width between about 0.25 mmand about 0.50 mm. In further examples, hole 204 has a diameter or widthbetween about 50% and about 90% of the inner diameter of microcatheter102. While FIG. 2 shows a single hole 204, microcatheter 102 may haveany other number of holes 204 positioned at any suitable locations.

To prevent the backflow of ambient fluid into microcatheter 102 throughhole 204, microcatheter 102 includes a one-way valve 208 at hole 204 orupstream from hole 204. In the example shown in FIG. 2 , the one-wayvalve 208 includes a flexible, tubular sleeve 210 positioned over hole204. Sleeve 210 may be formed of any suitable material (e.g.,polyurethane or silicone), and may be the same as or different from thematerial used for microcatheter 102. In some examples, sleeve 210 isformed of silicone and has a hardness between about 20 Shore A and about70 Shore A durometer.

Sleeve 210 may be formed to have a friction-fit over microcatheter 102so that sleeve 210 does not move along microcatheter 102 once sleeve 210is positioned over hole 204. To this end, sleeve 210 may have an innerdiameter slightly smaller (e.g., within about 0.05 mm) than the outerdiameter of microcatheter 102 so as to maintain a tight fit aroundmicrocatheter 102. For example, the inner diameter of sleeve 210 may beabout 0.02% to about 0.05% smaller than the outer diameter ofmicrocatheter 102, which may be sufficient to prevent backflow and stillallow fluid to exit from microcatheter 102. In some examples, a proximalend portion 212 (or, alternatively, a distal end portion 214) of sleeve210 may be a bonding area that is attached to side wall 206 by anadhesive 215 to prevent sleeve 210 from separating from side wall 206.The adhesive bonding area is not limited to proximal end portion 212 (ordistal end portion 214) of sleeve 210, as sleeve 210 may be bonded toside wall 206 by an adhesive at any additional or alternative locationprovided that sleeve 210 may partially separate from side wall 206 toallow fluid to exit microcatheter 102.

When fluid from fluid source 108 is not pushed through microcatheter 102so that no pressure is exerted on sleeve 210 through hole 204, sleeve210 forms a tight seal over hole 204 and prevents backflow of ambientfluid into microcatheter 102 through hole 204, as shown in FIG. 2 . Whenfluid from fluid source 108 is pushed through microcatheter 102, asindicated by arrow 302 shown in FIG. 3 , the fluid exerts a pressure onthe inner wall of sleeve 210 through hole 204 and pushes the non-adheredportion of sleeve 210 (e.g., the distal end portion 214 or the proximalend portion 212) away from side wall 206, thereby creating a small gapthrough which the fluid exits microcatheter 102 and enters intosurrounding tissue, as indicated by arrow 304. When the fluid flow stopsand the pressure drops, sleeve 210 returns to its original shape andposition to seal hole 204, as shown in FIG. 2 .

While FIGS. 2 and 3 show one hole 204, in other examples microcatheter102 may have multiple holes 204 formed within side wall 206, and asingle sleeve 210 may cover each of the holes 204. In alternativeexamples, different sleeves may be used for different holes 204.

In the examples in which the elution opening includes hole 204 withinside wall 206, a distal tip 216 of microcatheter 102 may be sealed witha sealant 218 to prevent the fluid from exiting through distal tip 216and to ensure that the fluid exits microcatheter 102 only through hole204. Any suitable sealant may be used, such as an adhesive, silicone, ora molten polyurethane.

Additionally or alternatively to using a sealant, distal tip 216 may beclosed and sealed with a sleeve having a closed distal tip, as shown inFIG. 4 . FIG. 4 is similar to FIG. 2 except that distal tip 216 ofmicrocatheter 102 is not sealed with a sealant, but rather sleeve 210has a closed distal tip 402 that covers distal tip 216. Thus, sleeve 210seals both distal tip 216 and hole 204. In some embodiments, sleeve 210may be secured to the distal end portion 202 of microcatheter 102 withan adhesive (e.g., on a distal side of hole 204). When fluid from fluidsource 108 is pushed through microcatheter 102, the friction-fit (and/oradhesive) of sleeve 210 prevents sleeve 210 from sliding off the distalend portion 202 of microcatheter 102. The fluid pushes the proximal endportion 212 of sleeve 210 away from side wall 206, creating a small gapthrough which the fluid may exit microcatheter 102 and enter intosurrounding tissue.

A sealed distal tip 216, as in the embodiments shown in FIGS. 2-4 , alsoenables the use of a stylet to implant microcatheter 102. For example, astainless steel stylet having an outer diameter smaller than the insidediameter of microcatheter 102 may be inserted into microcatheter 102 tostiffen microcatheter 102 so that microcatheter 102 may be guided to thetarget location. The stylet may then be removed after microcatheter 102has been implanted at the target location. In some examples, distal tip216 or distal tip 402 may be atraumatic to minimize or prevent injury totissue during implantation of the distal end portion of microcatheter102. For example, as shown in FIGS. 2-4 , distal tip 216 and distal tip402 are rounded.

Microcatheter 102 may be configured to be implanted in the body underimage guidance (e.g., fluoroscopy, radioscopy, etc.) and/or stereotacticguidance. For example, as shown in FIGS. 2 and 3 , microcatheter 102includes markers 220 (e.g., marker 220-1 and marker 220-2) positionedaround side wall 206 on either side of hole 204. Markers 220 may beformed of a fluorescent material (e.g., indocyanine green), radiopaquematerial (e.g., platinum, iridium, barium sulfate, bismuth compounds,tungsten, etc.), and/or any other material that may be imaged through analternative imaging modality (e.g., an imaging modality other thanvisible light imaging). Markers 220 may be embedded in, coated on,adhered to, or otherwise provided on microcatheter 102. In someexamples, markers 220 include separate rings or sleeves that frictionfit around microcatheter 102. In yet further examples, as shown in FIG.4 , one or more markers 220 may be provided on (e.g., embedded in,coated on, adhered to, etc.) a sleeve (e.g., sleeve 210) positionedaround microcatheter 102. For example, as shown in FIG. 4 , marker 220-1is provided on sleeve 210 and marker 220-2 is provided on side wall 206.However, marker 220-2 may also be provided on sleeve 210 on the oppositeside of hole 204 if marker 220-2 is sufficiently flexible to allowone-way valve 208 to open.

Markers 220 may be configured to indicate a location of the elutionopening (e.g., hole 204). For example, markers 220 may be positionedwithin a predetermined distance (e.g., within about 5 mm to about 10 mm)from hole 204 or from an open distal tip of microcatheter 102. Infurther examples, markers 220 may have a unique shape configured toindicate the elution opening (e.g., a ring or circle surrounding hole204, etc.). Under image guidance, markers 220 may be used duringimplantation to position hole 204 at the target location. While FIGS.2-4 show that microcatheter 102 or sleeve 210 includes two ring-likemarkers 220, microcatheter 102 and sleeve 210 may have any other number(e.g., one or more than two) and configuration of markers 220 as mayserve a particular implementation. Alternatively, microcatheter 102 andsleeve 210 may have no markers 220.

Referring again to FIG. 1 , when system 100 is implanted in therecipient microcatheter 102 is configured to receive fluid (e.g.,neurotherapeutic drugs) from fluid source 108. In some embodiments,fluid source 108 may be implanted in the recipient away from targetlocation 110. For example, target location 110 may be the brain of arecipient and fluid source 108 may be implanted in a thorax (e.g., apectoral region) of the recipient.

Due to the soft and flexible construction of microcatheter 102,microcatheter 102 may not be physically and mechanically suitable forimplantation from the head to the thorax to connect directly to thefluid source 108. For example, pulling on microcatheter 102 could damagemicrocatheter 102, such as by stretching, tearing, and/or constrictingmicrocatheter 102. Furthermore, a single microcatheter 102 that extendsfrom the head to the thorax may be damaged after implantation due to thelength of microcatheter 102 and the various twists, flexions, andmovements to which microcatheter 102 may be subjected during normalactivity by the recipient. Moreover, a single microcatheter 102 thatextends from the head to the thorax might be too long to implant with astylet.

To prevent these issues, the proximal end portion of microcatheter 102may be fluidically connected to the distal end portion of a morephysically and mechanically robust source catheter 104 by way ofconnection assembly 106. Thus, a shorter, softer, and more flexiblemicrocatheter 102 may be easily implanted with a stylet and, whenfluidically connected to source catheter 104 by way of connectionassembly 106, may receive fluid from fluid source 108 by way of sourcecatheter 104 and connection assembly 106.

FIGS. 5A and 5B show an illustrative implementation of source catheter104. FIG. 5A shows a side view of source catheter 104 and FIG. 5B showsa cross-sectional view of source catheter 104 as taken along the dashedline labeled VB-VB. Source catheter 104 includes a hollow tube 502 andmay be formed of any suitable material, such as polyurethane, silicone,and/or other biocompatible material. Source catheter 104 may be morephysically and mechanically robust than microcatheter 102. In someexamples, source catheter 104 has a hardness that is greater than thehardness of microcatheter 102. In some examples, the hardness of sourcecatheter 104 is about 70 Shore A durometer or less. In further examples,the hardness of source catheter 104 is between about 20 Shore A andabout 60 Shore A durometer. In yet further examples, the hardness ofsource catheter 104 is between about 30 Shore A and about 50 Shore Adurometer.

In some examples, as shown in FIGS. 5A and 5B, source catheter 104includes an inner braid 504 (e.g., a stainless steel braid) designed toresist kinking or excessive bending of source catheter 104. Braid 504may have any suitable number of braid strands and tightness. In someexamples, as shown in FIG. 5A, the distal end portion and/or proximalend portion of source catheter 104 does not include braid 504. Forexample, a distal end portion 506 and a proximal end portion 508 ofsource catheter 104 may each include a molded tip 510 to prevent frayingof the ends of braid 504. While FIGS. 5A and 5B show that sourcecatheter 104 includes inner braid 504, in other examples source catheter104 does not include inner braid 504.

Source catheter 104 may have any suitable wall thickness. In someexamples, the wall thickness of source catheter 104 is between about0.25 mm and about 0.50 mm. In other examples, the wall thickness ofsource catheter 104 is between about 10% and about 40% of the outerdiameter of source catheter 104. In yet further examples, the wallthickness of source catheter 104 is between about 15% and about 35% ofthe outer diameter of source catheter 104. In other examples, the wallthickness of source catheter 104 is between about 20% and about 30% ofthe outer diameter of source catheter 104. In further examples, the wallthickness of source catheter 104 is greater than the wall thickness ofmicrocatheter 102.

Source catheter 104 may have any suitable outer diameter and/or innerdiameter as may serve a particular implementation. In some examples, theouter diameter of source catheter 104 is about 1.5 mm or less. Infurther examples, the outer diameter of source catheter 104 is betweenabout 1.0 mm and about 1.5 mm. In some examples, the inner diameter ofsource catheter 104 is between about 0.5 mm and about 1.0 mm.

Due to the construction of source catheter 104, source catheter 104 maybe physically dissimilar from microcatheter 102 in various ways, such asin material, hardness, braiding, and/or one or more size measurements(e.g., outer diameter, inner diameter, and/or wall thickness). Thus,source catheter 104 may be configured to be tunneled under skin bypulling (e.g., with a tunneling tool) without damaging source catheter104.

Referring again to FIG. 1 , connection assembly 106 is configured tofluidically connect the proximal end portion of microcatheter 102 to thedistal end portion of source catheter 104, which may be larger and/ormore physically and mechanically robust than microcatheter 102. Thus,microcatheter 102 may be easily implanted and, when fluidicallyconnected to source catheter 104 by way of connection assembly 106(e.g., a cranial port), microcatheter 102 may receive fluid from fluidsource 108 by way of source catheter 104. In some examples, connectionassembly 106 may also be configured to be anchored to the body, such asto bone (e.g., the skull) and/or to tissue. Thus, connection assembly106 may also reduce or prevent application of stress or mechanicalforces on microcatheter 102, such as stresses or forces transmitted fromsource catheter 104.

In some examples, connection assembly is implemented by a cranial portthat may be secured to the skull of the recipient. FIGS. 6A-9B showillustrative embodiments of a cranial port 600 that may implementconnection assembly 106. FIG. 6A shows a top view of cranial port 600and FIG. 6B shows a side view of cranial port 600. FIGS. 6A and 6B showcranial port 600 unconnected to microcatheter 102 and source catheter104. As shown in FIGS. 6A and 6B, cranial port 600 includes a basemember 602 and a manifold 604 through which the proximal end portion ofmicrocatheter 102 may be fluidically connected to the distal end portionof source catheter 104. FIG. 7 shows a top view of cranial port 600 whenthe proximal end portion of microcatheter 102 and the distal end portionof source catheter 104 are connected to manifold 604.

Base member 602 may be formed of any suitable rigid or semi-rigidmaterial, such as a metal (e.g., stainless steel), a hard plastic (e.g.,polyethylene or polyether ether ketone (PEEK)), or a hard polymer (e.g.,polyurethane). As shown, base member 602 is formed of a top plate 602-1and a bottom plate 602-2 joined and held together, such as by anadhesive, screws, a snap-fit, a clip, or other suitable fastener.Alternatively, base member 602 may be a unitary body.

Base member 602 may be configured to be anchored to the recipient. Forexample, base member 602 includes two holes 606 formed in anchor tabs608 protruding from a main portion 610, which is configured to providestructural support for microcatheter 102 and manifold 604. Anchor tabs608 may be formed in top plate 602-1 and/or bottom plate 602-2. Holes606 may be used to attach base member 602 to the body (e.g., to theskull or to tissue), such as by bone screws 702 (see FIG. 7 ), sutures,staples, and/or other fasteners. In some examples, anchor tabs 608 areformed in both top plate 602-1 and bottom plate 602-2 and bone screws(or other fasteners) through holes 606 may also fasten top plate 602-1and bottom plate 602-2 together. While FIGS. 6A and 6B show two holes606, base member 602 may have any other suitable number of holes 606 asmay serve a particular implementation (e.g., one or more than two).Additionally or alternatively to holes 606, base member 602 may beattached to the body by an adhesive (e.g., a bone adhesive, tissue glue,etc.).

While FIGS. 6A and 6B show that base member 602 is generally circular,base member 602 may have any other suitable shape (e.g., circular,rectangular, oval, freeform, etc.). Base member 602 may also have anysuitable size. In some examples, base member 602 (e.g., main portion610) has a diameter or width between about 10 mm and about 25 mm. Basemember 602 (e.g., main portion 610) may have a thickness between about 3mm and about 5 mm. Thus, cranial port 600 may have a low profile andlittle to no cosmetic appearance when implanted in the recipient.

Manifold 604 includes a hollow chamber 612 with a first opening 614-1for connection with microcatheter 102 and a second opening 614-2 forconnection with source catheter 104 (collectively referred to as“openings 614”). As shown, manifold 604 may be formed integrally withbase member 602. Manifold 604 and openings 614 may be formed by formingwells or cavities in top plate 602-1 and/or bottom plate 602-2 and thenjoining top plate 602-1 and bottom plate 602-2. An adhesive and/or asealer, such as an O-ring (not shown) may be positioned between topplate 602-1 and bottom plate 602-2 and around the wells or cavities toprevent fluid leakage between top plate 602-1 and bottom plate 602-2when cranial port 600 is implanted in the recipient. In alternativeembodiments, base member 602 may be formed as a unitary body, such as byadditive manufacturing or by removing material through openings 614. Inyet further examples, manifold 604 may be formed separately and attachedto base member 602, such as by mechanical fastener or adhesive.

As shown in FIG. 7 , microcatheter 102 may be fluidically connected tomanifold 604 through first opening 614-1 by way of a first connector704-1, and source catheter 104 may be fluidically connected to manifold604 through second opening 614-2 by way of a second connector 704-2(collectively referred to as “connectors 704”). Connectors 704 may havea similar construction, potentially differing in size in someembodiments based on the sizes of microcatheter 102 and source catheter104. Since microcatheter 102 and source catheter 104 are eachfluidically connected to manifold 604, microcatheter 102 and sourcecatheter 104 are fluidically connected to one another through manifold604.

FIGS. 8A and 8B show an illustrative implementation of connector 704-1for microcatheter 102. FIG. 8A shows a cross-sectional side view ofconnector 704-1 and microcatheter 102 in an unassembled state, and FIG.8B shows a cross-sectional side view of connector 704-1 in an assembledstate with microcatheter 102. It will be understood that connector 704-2for source catheter 104 may have a similar construction, although“distal” and “proximal” descriptors may be reversed as appropriate.Accordingly, description of connector 704-2 will be omitted. As shown inFIGS. 8A and 8B, connector 704-1 includes an outer member 802, a sealingmember 804, and a pressing member 806.

Outer member 802 is a rigid or semi-rigid hollow tube having an innerchannel 808, a proximal end wall 810, and an open distal end 812. Outermember 802 is configured to fit into opening 614-1 of manifold 604.Accordingly, outer member 802 may be sized and shaped to substantiallymatch a size and shape of opening 614-1. For example, where opening614-1 is cylindrical, an outside shape of outer member 802 may also becylindrical. Outer member 802 may be secured to side walls of opening614-1 with an adhesive to seal any gaps between outer member 802 and theside walls of opening 614-1. Alternatively, outer member 802 may beformed integrally with base member 602. Inner channel 808 includes aproximal inner portion 808-1 and a distal inner portion 808-2 in whichsealing member 804 and/or pressing member 806 may be positioned.Proximal end wall 810 has an opening 814 through which a proximal endportion 816 of microcatheter 102 may be inserted when microcatheter 102is connected to connector 704-1. In some examples, a size of opening 814is about equal to the outer diameter of microcatheter 102. Open distalend 812 is open to allow sealing member 804 and/or pressing member 806to be inserted into inner channel 808. In some examples, outer member802 has a length between about 4 mm and about 8 mm. In further examples,inner channel 808 has a diameter or width of about 0.5 mm to about 1 mm.

Sealing member 804 is formed of a resilient material (e.g., silicone)and has an inner channel 818 through which proximal end portion 816 ofmicrocatheter 102 may be inserted when microcatheter 102 is connected toconnector 704-1. In some examples, sealing member 804 has a hardnessbetween about 20 Shore A durometer and about 50 Shore A durometer.Sealing member 804 is configured to be positioned in proximal innerportion 808-1 with minimal gaps or voids between sealing member 804 andouter member 802. In some examples, sealing member 804 is sized andshaped to substantially match a size and shape of inner channel 808(e.g., proximal inner portion 808-1). For example, where inner channel808 is cylindrical, sealing member 804 may also be cylindrical.

Pressing member 806 is configured to press against sealing member 804 tocompress sealing member 804 between pressing member 806 and proximal endwall 810. The pressure applied to sealing member 804 squeezes sealingmember 804 around the proximal end portion 816 of microcatheter 102 andagainst outer member 802, thereby creating a watertight seal to preventleakage of fluid through opening 814. Sealing member 804 also forms atight hold on microcatheter 102 to prevent disconnection ofmicrocatheter 102 from connector 704-1 but does so without limitingpatency of microcatheter 102. Pressing member 806 may be formed of anysuitable material that is harder than sealing member 804. For example,pressing member 806 may be formed of a hard plastic (e.g., PEEK), a hardpolymer (e.g., polyurethane), or a metal (e.g., stainless steel).

Pressing member 806 may have any suitable configuration and may operatein any suitable manner. In some examples, as shown in FIGS. 8A and 8B,pressing member 806 includes a threaded retainer screw configured to bepositioned in distal inner portion 808-2, which is also threaded tomatch the retainer screw. The retainer screw includes an inner channel820 through which the proximal end portion 816 of microcatheter 102 maybe inserted.

A distal end surface 822 of the retainer screw includes an engagementmember that may be used to tighten the retainer screw when the proximalend portion 816 of microcatheter 102 is positioned through inner channel818 and inner channel 820. As shown, the engagement member includes asocket 824 in distal end surface 822 of the retainer screw. The retainerscrew may be tightened by inserting a tool into socket 824 and using thetool to apply leverage from within socket 824 to rotate the retainerscrew within distal inner portion 808-2 of outer member 802 of connector704-1. For example, such a tool may be configured to be placed aroundouter member 802, the tool including an attached rod which may bepositioned within socket 824, so that outer member 802 and the tool bodycan be used in concert to apply the leverage to rotate the retainerscrew. In alternative embodiments, the engagement member may be a ridgeor protrusion that rises above distal end surface 822 of the retainerscrew and can be grasped by a tool to be pulled or pushed and therebyrotate the retainer screw. In other embodiments, the engagement membermay include one or more holes extending from a radially outer surface ofpressing member 806 towards inner channel 820 and a tool having anextended portion can be inserted into the one or more holes to providean accessible surface which can be grasped at the extended portion torotate the retainer screw.

Pressing member 806 may have a configuration other than a retainerscrew. For example, pressing member 806 may include a lid (with anopening for microcatheter 102 to pass through) that attaches (e.g., by asnap fit or threaded fit) to outer member 802 and presses directlyagainst sealing member 804. In other examples, pressing member 806 maybe a non-threaded hollow rigid body or semi-rigid body positioned withindistal inner portion 808-2 and held in place, such as by a snap-fit or alid (with an opening for microcatheter 102 to pass through) over distalend 812 of outer member 802.

As mentioned, outer member 802 may be secured in opening 614-1 with anadhesive. Microcatheter 102 may be connected to manifold 604 byinserting sealing member 804 and pressing member 806 into inner channel808 of outer member 802 with opening 814, inner channel 818, and innerchannel 820 aligned axially. The proximal end portion 816 ofmicrocatheter 102 may be inserted through pressing member 806, sealingmember 804, and then opening 814. Alternatively, microcatheter 102 mayfirst be inserted through pressing member 806 and sealing member 804,and then the assembly may be inserted into inner channel 808 of outermember 802. Pressing member 806 may be engaged (e.g., the retainer screwmay be tightened) to press against sealing member 804 and thus causesealing member 804 in turn to press against microcatheter 102, proximalend wall 810 of outer member 802, and an inner wall of inner chamber 808of outer member 802, which holds microcatheter 102 in position and alsocreates a seal against fluid traversing around microcatheter 102 withinouter member 802.

The distal end portion of source catheter 104 may also be connected tomanifold 604 in a manner similar to which the proximal end portion ofmicrocatheter 102 is connected to manifold 604. When microcatheter 102and source catheter 104 are connected to manifold 604, as shown in FIG.7 , manifold 604 of cranial port 600 acts as a fluid interface throughwhich microcatheter 102 is fluidically connected with source catheter104 so that fluid may flow from source catheter 104 into chamber 612 andthen through microcatheter 102, as indicated by arrows 706. Byindirectly connecting microcatheter 102 to source catheter 104 by way ofmanifold 604, forces from source catheter 104 (e.g., tugging, twisting,jolting, etc.) are minimized or inhibited from being transferred tomicrocatheter 102.

To prevent a proximal end 708 of microcatheter 102 and a distal end 710of source catheter 104 from being pushed too far into chamber 612,manifold 604 may include stoppers 616 formed inside chamber 612 nearopenings 614. The stoppers may be protrusions formed integrally with topplate 602-1 and/or bottom plate 602-2 or may be formed separately andattached to top plate 602-1 and/or bottom plate 602-2. Additionally oralternatively to stoppers 616, openings 614 may be angled relative tochamber 612 so that proximal end 708 of microcatheter 102 and distal end710 of source catheter 104 can be pushed far into chamber 612 withouthitting a chamber wall. In other examples, a sleeve having an outerdiameter greater than the diameter of inner channel 820 of pressingmember 806 (or inner channel 818 of sealing member 804) may be placedover the outside of the proximal end portion of microcatheter 102 toprevent proximal end 708 of microcatheter 102 from being pushed in toofar. That is, the sleeve is too large to fit at some point insideconnector 704-1 and thus connector 704-1 itself acts as a stopper. Asimilar sleeve may also be used over the outside of the distal endportion of source catheter 104 to prevent distal end 710 of sourcecatheter 104 from being pushed in too far.

Referring to FIGS. 6A, 6B, and 7 , base member 602 may also beconfigured to minimize or prevent stresses and forces that might beapplied to microcatheter 102. For example, as shown in FIGS. 6A and 6B,base member 602 includes an access hole 618 and a guide channel 620.Access hole 618 is a hole through base member 602 through which thedistal end of microcatheter 102 may be inserted for implantation at thetarget location. For example, access hole 618 may provide access to aburr hole 712 in the skull, as shown in FIG. 7 . Access hole 618 may beany size and shape as may serve a particular implementation.

Guide channel 620 extends from access hole 618 to an outside edge 622 ofbase member 602. As shown in FIGS. 6A and 7 , guide channel 620 is anopen channel (e.g., a groove) formed in a surface of base member 602,but guide channel 620 may alternatively be a closed channel (e.g., atube). Guide channel 620 is configured to hold microcatheter 102 inplace and limit movement of microcatheter 102 near access hole 618 toprevent dislocation of the implanted distal end of microcatheter 102.For example, guide channel 620 may have a width approximately equal tothe outer diameter of microcatheter 102. To hold microcatheter 102 inplace, guide channel 620 may be configured such that microcatheter 102may be “snapped” into place in guide channel 620 and prevented fromseparating from guide channel 620. In an alternative embodiment, cranialport 600 may include a cover (see FIG. 9B) that may be placed over basemember 602 to further restrict movement of microcatheter 102 and toprotect various components of cranial port 600.

The proximal end of guide channel 620 may be positioned at any locationrelative to opening 614-1 of cranial port 600. In some examples, theproximal end of guide channel 620 is positioned directly across (e.g.,180°) from opening 614-1 of cranial port 600 to maximize the distancemicrocatheter 102 is wrapped around base member 602. In other examples,the proximal end of guide channel 620 may be positioned less than 180°or more than 180° from opening 614-1 of cranial port 600 (e.g., at 210°,135°, 90°, 45°, etc.).

As shown in the embodiment of FIG. 7 , microcatheter 102 wraps looselyaround (e.g., may not be in contact with) base member 602. In otherexamples, microcatheter 102 may be wrapped tightly around outside edge622 of base member 602 or over base member 602.

By the use of the cranial port 600 fixed to the skull to holdmicrocatheter 102 firmly in position within guide channel 620 and toconnect microcatheter 102 and source catheter 104 through respectiveconnectors 704-1 and 704-2 into manifold 604 without direct physicalconnection between microcatheter 102 and source catheter 104,microcatheter 102 may be partially or substantially mechanicallyisolated from external forces. For example, movement of a portion ofmicrocatheter 102 extending between access hole 618 and first opening614-1 may be isolated from disturbing a portion of microcatheter 102extending within the skull by microcatheter 102 being held in positionwithin guide channel 620 and by cranial port 600 being fixed to theskull. For another example, movement of source catheter 104 may beisolated from disturbing the portion of microcatheter 102 extendingwithin the skull by source catheter 104 being positioned in secondconnector 704-2, by source catheter 104 being physically distanced frommicrocatheter 102 by the fluidic coupling through manifold 604, bymicrocatheter 102 being held in position within guide channel 620, andby cranial port 600 being fixed to the skull. In general, the portion ofmicrocatheter 102 extending within the skull may be protected in severalways from movement within the skull which, absent the cranial port 600,might otherwise occur due to application of external forces.

FIG. 9A shows a top view of another illustrative implementation ofcranial port 600. FIG. 9A is similar to FIG. 6A except that in FIG. 9A,cranial port 600 includes an outer guide channel 902 towards outsideedge 622 of base member 602 in which microcatheter 102 may be secured.Outer guide channel 902 may be configured similarly to guide channel620. Outer guide channel 902 may connect to opening 614-1. In someexamples, outer guide channel 902 is deep enough so that microcatheter102 does not protrude from outside edge 622 of base member 602 or abovean upper surface of base member 602.

FIG. 9B shows a top view of an optional cover 904 covering cranial port600 shown in FIGS. 6A, 6B, 7, and 9A. Cover 904 is configured to cover atop surface and outside edge 622 of base member 602. Cover 904 may beattached to base member 602 in any suitable way, such as by a fastener,a snap-fit, a threaded fit, and/or an adhesive. When placed over basemember 602 of FIG. 9A, cover 904 may also cover outer guide channel 902to protect microcatheter 102 and prevent separation of microcatheter 102from outer guide channel 902. Thus, cover 904 may completely covermicrocatheter 102 so that no part of microcatheter 102 is exposedoutside of cover 904. Cover 904 may include an opening (not shown inFIG. 9B) corresponding to opening 614-2 so that source catheter 104 mayconnect to manifold 604 through cover 904.

In the examples described above, connection assembly 106 (see FIG. 1 )is implemented by cranial port 600. In alternative examples, connectionassembly 106 may be implemented by a coupling that directly connects theproximal end of microcatheter 102 with the distal end of source catheter104. For example, FIGS. 10A and 10B show another illustrativeimplementation of connection assembly 106. As shown, connection assembly106 is implemented by a coupling 1000. FIG. 10A shows coupling 1000 inan unassembled state and FIG. 10B shows coupling 1000 in an assembledstate connected to microcatheter 102 and source catheter 104.

Coupling 1000 includes a microcatheter connector 1002 and a sourcecatheter connector 1004 connected end-to-end. Connectors 1002 and 1004are similar to connectors 704-1 and 704-2 and therefore will not bedescribed in detail. In some examples, outer members of connectors 1002and 1004 are formed as a unitary body, as shown in FIGS. 10A and 10B.Alternatively, outer members of connectors 1002 and 1004 are formedseparately and joined together, such as by an adhesive, snap-fit, afastener, a threaded fit, or other suitable attachment. In someexamples, as shown in FIGS. 10A and 10B, coupling 1000 includes anchortabs 1006 so that coupling 1000 may be attached to the body (e.g., tobone).

In alternative embodiments, such as when microcatheter 102 and sourcecatheter 104 have a similar size, microcatheter 102 and source catheter104 may be connected directly, such as by an adhesive between a proximaltip of microcatheter 102 and a distal tip of source catheter 104.However, a direct connection may not be suitable in certain cases wheremicrocatheter 102 and source catheter 104 are physically dissimilarand/or where source catheter 104 may exert stresses or forces onmicrocatheter 102.

Referring again to FIG. 1 , the proximal end of source catheter 104 isconnected to fluid source 108. Fluid source 108 may be implanted in thebody, such as in the pectoral fascia between the skin and muscle.

In some examples, fluid source 108 may be implemented by a fill port.FIGS. 11A and 11B show an illustrative implementation of a fill port1100 that may implement fluid source 108. FIG. 11A shows a top view offill port 1100 and FIG. 11B shows a cross-sectional side view of fillport 1100 taken along the dashed line labeled XIB-XIB.

As shown in FIGS. 11A and 11B, fill port 1100 includes a main body 1102,a septum 1104, and a chamber 1106. Main body 1102 is formed of a rigidmaterial, such as a hard plastic (e.g., PEEK) or a metal. Main body 1102includes a cavity 1108 formed therein defined by side walls 1110 and anopening 1112 in an upper surface of main body 1102. Opening 1112provides access to cavity 1108. As shown in FIG. 11B, inner surfaces ofside walls 1110 are sloped or curved inward so that a size of opening1112 is smaller than the size of cavity 1108. Alternatively, side walls1110 may have any other suitable configuration (e.g., straight or slopedor curved outward) as may serve a particular implementation. Main body1102 may be atraumatic, such as by having rounded edges and smoothcurves. Main body 1102 may further include anchor portion 1114 withholes 1116 for attaching main body 1102 to the body, such as by bonescrews, sutures, and/or staples. Main body 1102, cavity 1108, andopening 1112 may each have any suitable shape and size. For example,FIG. 11A shows that main body 1102, cavity 1108, and opening 1112 have agenerally circular or rounded shape, as seen from a top view. In someexamples, an outer diameter of main body 1102 is between about 18 mm andabout 25 mm. In some examples, a diameter of cavity 1108 may be betweenabout 5 mm and about 20 mm. In some examples, a thickness of main body1102 may be between about 8 mm and about 10 mm.

Septum 1104 includes a sac 1118 and a soft gel 1120 in sac 1118. Sac1118 may be formed, for example, of a soft elastomer (e.g., silicone),and gel 1120 may be any suitable soft gel (e.g., silicone gel). Septum1104 is positioned in opening 1112 to seal off opening 1112. Septum 1104may be attached to side walls 1110 with an adhesive. A bottom surface1122 of septum 1104, side walls 1110 of cavity 1108, and a bottomsurface 1124 of cavity 1108 define inner walls of chamber 1106. Chamber1106 is a fluid chamber for receiving and/or holding a fluid (e.g., aneurotherapeutic drug) to be delivered to the target location by way ofsource catheter 104 and microcatheter 102.

Main body 1102 includes an opening 1126 in a side wall 1110 tofluidically connect source catheter 104 with chamber 1106. Sourcecatheter 104 may be fluidically connected with chamber 1106 by way of aconnector, as shown in FIG. 12 . FIG. 12 is similar to FIG. 11B exceptthat source catheter 104 is connected to fill port 1100 by way of aconnector 1202. Connector 1202 may have any suitable configuration. Asshown in FIG. 12 , connector 1202 includes an elastomer sleeve 1204positioned over the proximal end portion of source catheter 104. Sleeve1204 may be formed to have a tight, friction-fit over source catheter104 and a tight, friction-fit within opening 1126. For example, sleeve1204 may have an inner diameter that is slightly smaller than the outerdiameter of source catheter 104, and an outer diameter that is slightlylarger than the inner diameter of opening 1126. An outer surface ofsleeve 1204 may also include a protruding seal 1206 around thecircumference of sleeve 1204. Seal 1206 is configured to engage with acorrespondingly shaped channel in opening 1126 to secure sleeve 1204 inopening 1126 and prevent sleeve 1204 and source catheter 104 fromdisconnecting from fill port 1100. In alternative examples, connector1202 may be implemented by a connector similar to connector 704-2 usedfor connecting source catheter 104 to cranial port 600. In someexamples, connector 1202 and the correspondingly shaped opening 1126 mayalso be used in cranial port 600 in place of connector 704-1 and/orconnector 704-2 and opening 614-1 and/or 614-2.

Chamber 1106 may be filled with a fluid (e.g., a neurotherapeutic drug)by inserting a non-coring needle through an upper surface 1128 of septum1104 and into chamber 1106. As the fluid is pushed into chamber 1106under pressure, the pressure pushes the fluid through source catheter104, through connection assembly 106 (e.g., manifold 604 of cranial port600), and through microcatheter 102 from which the fluid elutes to thetarget location. After the non-coring needle is removed from fill port1100, gel 1120 resumes its crosslinked orientation, allowing septum 1104to heal from the puncture.

The fluid may be pushed through system 100 in any suitable way. Forexample, in some implementations the fluid may be pushed through system100 by a syringe connected to the non-coring needle.

FIG. 13 shows another implementation for pushing fluid through system100 using an external pump 1302. FIG. 13 is similar to FIG. 1 exceptthat, in FIG. 13 , external pump 1302 (e.g., external to the recipient)is connected to source catheter 104 to push fluid through system 100.External pump 1302 may be connected to source catheter 104 in anysuitable way, such as through a percutaneous access port or a cannula.External pump 1302 may be fluidically connected to an external fluidsource (not shown) to provide fluid from the fluid source tomicrocatheter 102 by way of source catheter 104 and connection assembly106.

FIG. 14 shows yet another implementation for pushing fluid throughsystem 100 using an implantable pump 1402. FIG. 14 is similar to FIG. 1except that, in FIG. 14 , implantable pump 1402 is implanted in therecipient and connected between source catheter 104 and fluid source 108(e.g., chamber 1106 of fill port 1100) to push fluid through system 100.Alternatively, implantable pump 1402 may be fluidically connected tosource catheter 104 with fluid source 108 located in between sourcecatheter 104 and implantable pump 1402. In yet further embodiments,implantable pump 1402 and fluid source 108 may be integrated as a singledevice. Fluid source 108 may be implantable in the recipient or may beexternal to the recipient.

In the implementations of FIGS. 13 and 14 , source catheter 104 may befluidically connected to external pump 1302 or implantable pump 1402 inany suitable way, including in any way described herein. In someexamples, a proximal end portion of source catheter 104 is configured toconnect to implantable pump 1402. Pumps 1302 and 1402 may be implementedby any suitable pump, such as a low-pressure pump or a peristaltic pump.

In embodiments in which an external device (e.g., a syringe andnon-coring needle, external pump 1302, etc.) is used to push fluidthrough system 100, fluid source 108 may include an alignment unitconfigured to facilitate proper alignment of the external device withupper surface 1128 of septum 1104. In some examples, the alignment unitincludes a metal object (e.g., a rod, a bead, a plate, a screw, etc.)that may be detected by the external device (e.g., by a metal detector,a magnetometer, etc.). The metal object may be included in (e.g.,embedded in, attached to, etc.) fluid source 108 (e.g., in or on mainbody 1102). In some examples, the metal object includes bone screws orstaples used to secure fluid source 108 to the body through holes 1116.In further examples, one or more components of fluid source 108 may beformed of metal (e.g., main body 1102).

In other examples, the alignment unit includes an internal alignmentcircuit in fluid source 108 that inductively couples to an externalalignment circuit included in an external device (e.g., an externalpump, a syringe, an alignment device, etc.). For example, FIG. 15A showsa functional diagram of an illustrative implementation of an internalalignment circuit 1502 in fluid source 108 and an external alignmentcircuit 1504 in an external device 1506. As shown, internal alignmentcircuit 1502 includes a conductive coil 1508 electrically connected witha load 1510 (e.g., a resistor). Internal alignment circuit 1502 mayinclude any additional or alternative components as may serve aparticular implementation (e.g., capacitors). External alignment circuit1504 includes a conductive coil 1512 electrically connected to a currentsource 1514 and a measurement circuit 1516. External alignment circuit1504 may include any additional or alternative components as may serve aparticular implementation.

Current source 1514 is configured to generate a current throughconductive coil 1512, and the current is inductively coupled ontoconductive coil 1508 when external device 1506 is positioned near fluidsource 108. The inductively coupled energy is then dissipated in load1510. Measurement circuit 1516 is configured to measure the currentdrain or power transfer caused by internal alignment circuit 1502.Measurement circuit 1516 may have any suitable configuration. Themeasured current drain or power transfer increases as conductive coil1512 is brought into alignment with axis 1518 of conductive coil 1508. Amaximum current drain or power transfer occurs when conductive coil 1512is aligned along the same axis 1518 of conductive coil 1508. Thus,external device 1506 can be brought into proper positional alignmentwith fluid source 108 based on the current drain measured by measurementcircuit 1516 in external device 1506. That is, external device 1506senses alignment by identifying a physical location where there is amaximum power transfer.

Conductive coil 1508 of internal alignment circuit 1502 may be locatedin any suitable location within fluid source 108. For example, FIG. 15Bshows an illustrative implementation of internal alignment circuit 1502in fill port 1100. As shown, conductive coil 1508 is positioned withinside walls 1110 around chamber 1106. Axis 1518 of conductive coil 1508may be positioned at any suitable location, such as at the center ofchamber 1106. However, conductive coil 1508 may be positioned at anysuitable location within side walls 1110 and/or main body 1102. With theconfiguration shown in FIG. 15B, an external device (e.g., a needleand/or pump) may be properly aligned with fill port 1100 so that theneedle penetrates septum 1104 and pushes fluid into chamber 1106 andthrough system 100.

While FIG. 15B shows one conductive coil 1508, fill port 1100 mayinclude any other number of conductive coils and internal alignmentcircuits 1502 as may serve a particular implementation (e.g., one orthree or more). For example, FIG. 16 shows another illustrativeimplementation of internal alignment circuit 1502 in fill port 1100. Asshown in FIG. 16 , a first internal conductive coil 1602-1 and a secondinternal conductive coil 1602-2 are positioned within side walls 1110.Axes 1604-1 and 1604-2 of conductive coils 1602-1 and 1602-2 may bepositioned with any suitable orientation. While FIG. 16 shows twoconductive coils 1602, fill port 1100 may include any other number ofconductive coils and internal alignment circuits as may serve aparticular implementation (e.g., one or three or more). Conductive coils1602-1 and 1602-2 may be connected to the same load or to differentloads.

With the systems, assemblies, and methods described herein, variousdisorders and conditions may be treated more efficiently and with fewerside effects to the recipient. For example, system 100 may be used forthe treatment of cancer (e.g., glioblastoma, tumors, etc.), Parkinson'sdisease, epilepsy (e.g., status epilepticus), Alzheimer's disease,Huntington's disease, multiple sclerosis, and psychiatric applications(e.g., depression, anxiety, etc.). System 100 may also be used for thetreatment of other non-brain diseases or conditions (e.g., cancer). Bydelivering drugs directly to the target location instead of byintravenous administration, system 100 may avoid various system sideeffects and complications with conventional treatment methods.

In the examples described herein, various components and tools used toimplement system 100 may be provided as a kit. For example, a kit mayinclude any one or more of microcatheter 102, sleeve 210, an adhesiveand applicator for attaching sleeve 210 to microcatheter 102, a styletfor implanting the distal end portion of microcatheter 102, a measuringtool (e.g., a ruler for measuring a proper length of microcatheter 102,and a knife or scissors for cutting microcatheter 102. Additionally, akit may include any one or more of cranial port 600 or coupling 1000,connectors 704 (e.g., outer member 802, sealing member 804, pressingmember 806, and/or a sleeve stopper), an adhesive and/or a sealer (e.g.,an O-ring), fasteners (e.g., bone screws and screwdriver), a hex key orother tool (e.g., lever) for tightening pressing member 806 (retainerscrew), and cover 904 for cranial port 600. Additionally, a kit mayinclude any one or more of source catheter 104, a tunneling tool (forimplanting source catheter 104), fluid source 108 (e.g., fill port1100), connector 1202 (e.g., sleeve 1204), a needle (e.g., a non-coringneedle), a syringe, a pump (e.g., external pump 1302, implantable pump1402), external device 1506, and a knife or scissors for cutting sourcecatheter 104. Additionally, a kit may include a sterilization kit forsterilizing an implant site and/or a fluid injection site on the body.

Various modifications may be made to system 100 and/or any of itscomponents. For example, FIGS. 17A and 17B show another illustrativeimplementation of microcatheter 102. As shown, microcatheter 102 isimplemented by a dual lumen catheter 1700. FIG. 17A shows a side view ofdual lumen catheter 1700 and FIG. 17B shows a cross-sectional view ofdual lumen catheter taken along the dashed line labeled XVIIB-XVIIB. Asshown, dual lumen catheter 1700 includes a stylet lumen 1702 and a fluiddelivery lumen 1704 side-by-side. A proximal end of stylet lumen 1702 isopen while a distal end of stylet lumen 1702 is closed so that a styletmay be inserted into stylet lumen 1702 and used to implant a distal endof dual lumen catheter at a target location. A proximal end portion offluid delivery lumen 1704 is configured to be fluidically connected tothe distal end portion of source catheter 104, such as in any of theways described herein. Accordingly, as shown in FIG. 17A the proximalend portion of fluid delivery lumen 1704 is longer than the proximal endportion of stylet lumen 1702. The distal end portion of fluid deliverylumen 1704 is configured to be implanted at the target location andelute a fluid to the target location through an elution opening (notshown). The elution opening may be configured in any way describedherein.

In another modification, fluid source 108 may be included in cranialport 600 so that source catheter 104 is not needed. For example,manifold 604 may implement a fill port (e.g., chamber 612 of manifold604 may implement chamber 1106 of fill port 1100). Accordingly, cranialport 600 may include a septum to allow chamber 612 to be filled withfluid by an external device.

As mentioned above, sleeve 210 may be used in system 100 as a one-wayvalve to prevent fluid from flowing back into microcatheter 102 throughelution opening 204. It will be recognized that this one-way sleevevalve may be used in applications other than for a microcatheter and/orfor systems other than system 100. For example, sleeve 210 may be usedas a one-way valve for any other catheter (e.g., a central venouscatheter). Additionally, sleeve 210 may be used in other medical andnon-medical applications.

The systems, assemblies, and methods described herein offer numerousbenefits and advantages over conventional systems, assemblies, andmethods. For example, with the systems, assemblies, and methodsdescribed herein neurotherapeutic drugs may be delivered directly to atarget location within the recipient with minimal systemic side effects.Additionally, the distal end portion of the microcatheter may bepositioned at or near the target location, thereby increasing theefficiency of drug delivery.

Furthermore, the microcatheter and the source catheter may each beconfigured to suit the different functions that each catheter serveswithout sacrificing performance of the catheters or the system as awhole. For example, the microcatheter may be small, soft, and flexibleso that it can be implanted in or near delicate tissue, such as braintissue, without injuring the tissue. The microcatheter may also beimplanted at the target location under stereotactic guidance and/orimage guidance (e.g., radioscopic or fluorescence guidance). On theother hand, the source catheter may be more physically and mechanicallyrobust to prevent kinking or collapsing and to allow more physicallydemanding implantation techniques, such as tunneling and pulling. Thus,the fluid source may be implanted at a location far away from the targetlocation. For example, the target location may be the brain while thefluid source may be implanted at the thorax, which has more space thanthe head and less hair that carries pathogens. In this way, the fluidsource does not protrude from the head and is less susceptible toreceiving pathogens that are commonly carried in hair. Moreover, thisconfiguration may be more comfortable and cosmetically appealing to therecipient.

Furthermore, the systems, assemblies, and methods described herein maypermit more frequent or even on-demand delivery of drug to the targetlocation. For example, a drug may be administered to the target locationas needed, such as at the onset of a seizure. A drug may also bedelivered to the target location with more frequency and with greaterease. For example, the drug may be delivered to the target location(e.g., the brain) with a simple injection through the recipient's skininto the fluid source. Moreover, the drug may be replenished or evenchanged as needed without surgical intervention.

Advantages and features of the present disclosure can be furtherdescribed by the following statements.

-   -   1. A drug delivery system implantable in a recipient,        comprising: a connection assembly; a source catheter comprising:        a proximal end portion configured to be fluidically connected to        a fluid source configured to provide a fluid; and a distal end        portion configured to be fluidically connected to the connection        assembly; and a microcatheter comprising: a proximal end portion        configured to be fluidically connected to the connection        assembly; and a distal end portion comprising an elution opening        configured to elute the fluid to a target location within the        recipient.    -   2. The drug delivery system of statement 1, wherein the target        location comprises a brain of the recipient.    -   3. The drug delivery system of statement 2, wherein the distal        end portion of the microcatheter is implantable in parenchymal        tissue of the brain.    -   4. The drug delivery system of statement 2 or 3, wherein the        fluid comprises a neurotherapeutic drug.    -   5. The drug delivery system of any of statements 2-4, wherein        the connection assembly comprises a cranial port comprising: a        base member configured to be attached to a skull of the        recipient; and a manifold on the base member; wherein the        proximal end portion of the microcatheter is configured to be        fluidically connected to the distal end portion of the source        catheter by way of the manifold.    -   6. The drug delivery system of statement 5, wherein the manifold        is integrally formed with the base member.    -   7. The drug delivery system of statement 5 or 6, wherein the        base member comprises an access hole for accessing a burr hole        in the skull, the burr hole providing access to the brain.    -   8. The drug delivery system of statement 7, wherein: the base        member further comprises a guide channel extending from the        access hole to an outside edge of the base member; and the guide        channel is configured to secure the microcatheter when the        distal end portion of the microcatheter is implanted in the        brain.    -   9. The drug delivery system of any of statements 5-8, further        comprising a first connector for connecting the microcatheter to        the manifold, the first connector comprising: a hollow first        outer member having a first inner portion, a proximal end wall,        and an opening in the proximal end wall; a first sealing member        having a first inner channel configured to receive the proximal        end portion of the microcatheter, the first sealing member being        configured to be positioned in the first inner portion of the        first outer member; and a first pressing member configured to        press the first sealing member to compress the first sealing        member around the proximal end portion of the microcatheter when        the proximal end portion of the microcatheter is positioned        through the first inner channel of the first sealing member.    -   10. The drug delivery system of statement 9, wherein the first        sealing member is configured to seal the first inner portion of        the first outer member when pressed by the first pressing        member.    -   11. The drug delivery system of statement 9 or 10, wherein an        inner diameter of the first inner channel of the first sealing        member is about equal to or less than an outer diameter of the        microcatheter.    -   12. The drug delivery system of any of statements 9-11, wherein:        the first inner portion of the first outer member comprises a        distal inner portion and a proximal inner portion; the first        sealing member is configured to be positioned in the proximal        inner portion of the first outer member; and the first pressing        member is configured to be positioned in the distal inner        portion of the first outer member.    -   13. The drug delivery system of statement 12, wherein: the        distal inner portion of the first outer member is threaded; and        the first pressing member comprises a retainer screw.    -   14. The drug delivery system of any of statements 9-13, further        comprising a second connector for connecting the source catheter        to the manifold, the second connector comprising: a hollow        second outer member having a second inner portion, a distal end        wall, and an opening in the distal end wall; a second sealing        member having a second inner channel configured to receive the        distal end portion of the source catheter, the second sealing        member being configured to be positioned in the second inner        portion of the second outer member; and a second pressing member        configured to press the second sealing member to compress the        second sealing member around the distal end portion of the        source catheter when the distal end portion of the source        catheter is positioned through the second inner channel of the        second sealing member.    -   15. The drug delivery system of any of statements 9-14, wherein:        the manifold comprises a first opening for connecting the        microcatheter and a second opening for connecting the source        catheter; and the first outer member is secured in the first        opening.    -   16. The drug delivery system of any of the preceding statements,        wherein a hardness of the microcatheter is less than a hardness        of the source catheter.    -   17. The drug delivery system of any of the preceding statements,        wherein a hardness of the microcatheter is between about 20        Shore A durometer and about 50 Shore A durometer.    -   18. The drug delivery system of any of the preceding statements,        wherein the source catheter comprises an inner braid.    -   19. The drug delivery system of any of the preceding statements,        wherein at least one of: an inner diameter of the microcatheter        is smaller than an inner diameter of the source catheter; or an        outer diameter of the microcatheter is smaller than an outer        diameter of the source catheter.    -   20. The drug delivery system of statement 19, wherein the outer        diameter of the microcatheter is between about 0.5 mm and about        1.0 mm.    -   21. The drug delivery system of statement 19 or 20, wherein the        outer diameter of the source catheter is between about 1.0 mm        and about 1.5 mm.    -   22. The drug delivery system of any of statements 19-21, wherein        the inner diameter of the microcatheter is between about 0.30 mm        and about 0.80 mm.    -   23. The drug delivery system of any of statements 19-22, wherein        the inner diameter of the source catheter is between about 0.5        mm and about 1.0 mm.    -   24. The drug delivery system of any of the preceding statements,        wherein a wall thickness of the microcatheter is between about        0.05 mm and about 0.15 mm.    -   25. The drug delivery system of any of the preceding statements,        wherein a diameter of the elution opening is between about 0.25        mm and about 0.5 mm.    -   26. The drug delivery system of any of the preceding statements,        wherein the microcatheter is configured to be implanted in the        recipient under at least one of image guidance or stereotactic        guidance.    -   27. The drug delivery system of any of the preceding statements,        wherein the microcatheter further comprises one or more imaging        markers.    -   28. The drug delivery system of any of the preceding statements,        wherein the microcatheter is configured to be implanted in the        recipient with a stylet.    -   29. The drug delivery system of any of the preceding statements,        wherein: a distal tip of the microcatheter is sealed; the        elution opening is in a side wall of the distal end portion of        the microcatheter; and the microcatheter further comprises a        one-way valve at the elution opening.    -   30. The drug delivery system of statement 29, wherein the        one-way valve comprises a flexible sleeve on the microcatheter        and covering the elution opening.    -   31. The drug delivery system of statement 30, wherein a distal        end portion of the sleeve or a proximal end portion of the        sleeve is adhered to the side wall of the distal end portion of        the microcatheter.    -   32. The drug delivery system of statement 30 or 31, wherein: the        sleeve has a closed distal tip; and the distal tip of the        microcatheter is sealed by the closed distal tip of the sleeve.    -   33. The drug delivery system of any of the preceding statements,        wherein the connection assembly comprises a coupling.    -   34. The drug delivery system of any of the preceding statements,        wherein the fluid source comprises: a body member comprising a        cavity and an opening, in a surface of the body member, to the        cavity; a septum positioned in the opening and comprising a gel        in a sac; and a chamber defined by the cavity of the body member        and the septum.    -   35. The drug delivery system of any of the preceding statements,        further comprising an implantable pump configured to push the        fluid from the fluid source to the target location by way of the        source catheter and the microcatheter.    -   36. The drug delivery system of any of the preceding statements,        further comprising an external device configured to push the        fluid from the fluid source to the target location by way of the        source catheter and the microcatheter.    -   37. The drug delivery system of statement 36, wherein the        external device comprises a syringe or an external pump.    -   38. The drug delivery system of statement 36 or 37, wherein the        fluid source comprises an alignment unit configured to        facilitate alignment of the external device with the fluid        source.    -   39. The drug delivery system of statement 38, wherein the        alignment unit comprises one or more metal objects configured to        be detected by a metal detector on the external device.    -   40. The drug delivery system of statement 38 or 39, wherein: the        alignment unit comprises an alignment circuit including a first        conductive coil electrically connected to a load; and the first        conductive coil is configured to inductively couple with a        second conductive coil included in the external device when the        external device is aligned with the fluid source.    -   41. A method comprising: implanting a distal end portion of a        microcatheter at a target location within a recipient, the        distal end portion of the microcatheter comprising an elution        opening for eluting a fluid to the target location; fluidically        connecting a proximal end portion of the microcatheter to a        distal end portion of a source catheter by way of a connection        assembly; and fluidically connecting a proximal end portion of        the source catheter to a fluid source configured to provide the        fluid to the microcatheter.    -   42. The method of statement 41, wherein the target location        comprises a brain of the recipient.    -   43. The method of statement 42, wherein the target location        comprises parenchymal tissue of the brain.    -   44. The method of statement 42 or 43, wherein the fluid        comprises a neurotherapeutic drug.    -   45. The method of any of statements 42-44, wherein the        implanting the distal end portion of the microcatheter        comprises: forming a burr hole in a skull of the recipient; and        inserting the distal end portion of the microcatheter through        the burr hole.    -   46. The method of statement 45, wherein: the connection assembly        comprises a cranial port comprising: a base member; and a        manifold on the base member; the method further comprises        attaching the cranial port to the skull; and the fluidically        connecting the proximal end portion of the microcatheter to the        distal end portion of the source catheter by way of the        connection assembly comprises: connecting the proximal end        portion of the microcatheter to the manifold; and connecting the        distal end portion of the source catheter to the manifold.    -   47. The method of statement 46, wherein: the base member        comprises an access hole for accessing the burr hole and a guide        channel extending from the access hole to an outside edge of the        base member; and the method further comprises positioning the        microcatheter in the guide channel.    -   48. The method of statement 46 or 47, wherein the connecting the        proximal end portion of the microcatheter to the manifold        comprises: positioning a first sealing member in a first inner        portion of a hollow first outer member, the first outer member        having a proximal end wall and an opening in the proximal end        wall; inserting the proximal end portion of the microcatheter        through a first inner channel of the first sealing member and        through the opening in the proximal end wall; and causing a        first pressing member to press the first sealing member to        compress the first sealing member around the proximal end        portion of the microcatheter.    -   49. The method of statement 48, wherein: the first inner portion        of the first outer member comprises a distal inner portion and a        proximal inner portion; the first sealing member is positioned        in the proximal inner portion of the first outer member; and the        causing the first pressing member to press the first sealing        member comprises positioning the first pressing member in the        distal inner portion of the first outer member.    -   50. The method of statement 49, wherein: the distal inner        portion of the first outer member is threaded; the first        pressing member comprises a retainer screw; and the causing the        first pressing member to press the first sealing member further        comprises tightening the retainer screw.    -   51. The method of any of statements 48-50, wherein the        connecting the distal end portion of the source catheter to the        manifold comprises: positioning a second sealing member in a        second inner portion of a hollow second outer member, the second        outer member having a distal end wall and an opening in the        distal end wall; inserting the distal end portion of the source        catheter through a second inner channel of the second sealing        member and through the opening in the distal end wall; and        causing a pressing member to press the second sealing member to        compress the second sealing member around the distal end portion        of the source catheter.    -   52. The method of any of statements 41-51, wherein the        implanting the distal end portion of the microcatheter        comprises: inserting a stylet in the distal end portion of the        microcatheter; using the stylet to position the distal end        portion of the microcatheter at the target location; and        removing the stylet from the microcatheter after the distal end        portion of the microcatheter is positioned at the target        location.    -   53. The method of any of statements 41-52, wherein the        microcatheter is implanted in the recipient under at least one        of image guidance or stereotactic guidance.    -   54. The method of statement 53, wherein the microcatheter        comprises one or more imaging markers.    -   55. The method of any of statements 41-54, further comprising:        implanting the fluid source in the recipient; and implanting the        source catheter in the recipient.    -   56. The method of statement 55, wherein the implanting the        source catheter comprises tunneling the source catheter through        the recipient from the fluid source to the proximal end portion        of the microcatheter.    -   57. The method of statement 55 or 56, wherein the fluid source        is implanted in a thorax of the recipient.    -   58. The method of any of statements 41-57, further comprising:        providing the fluid to the fluid source; and pushing the fluid        from the fluid source to the target location by way of the        source catheter and the microcatheter.    -   59. The method of statement 58, further comprising implanting an        implantable pump; wherein the pushing the fluid from the fluid        source to the target location is performed by the implantable        pump.    -   60. The method of statement 58 or 59, further comprising        aligning, by way of an alignment unit included in the fluid        source, an external device with the fluid source; wherein at        least one of the providing the fluid to the fluid source or the        pushing the fluid from the fluid source to the target location        is performed with the external device.    -   61. A connection assembly for an implantable drug delivery        system, the connection assembly comprising: a base member        configured to be attached to a skull of a recipient; and a        manifold on the base member and configured to couple a proximal        end portion of a microcatheter to a distal end portion of a        source catheter.    -   62. The connection assembly of statement 61, wherein the        manifold is integrally formed with the base member.    -   63. The connection assembly of statement 61 or 62, wherein the        base member comprises an access hole for accessing a burr hole        in the skull, the burr hole providing access to a brain of the        recipient.    -   64. The connection assembly of statement 63, wherein: the base        member further comprises a first guide channel extending from        the access hole to an outside edge of the base member; and the        first guide channel is configured to secure the microcatheter        when a distal end portion of the microcatheter is implanted in        the brain of the recipient.    -   65. The connection assembly of statement 64, wherein: the base        member further comprises a second guide channel extending along        the outside edge of the base member from the first guide channel        to an opening to the manifold; and the second guide channel is        configured to secure the microcatheter when the distal end        portion of the microcatheter is implanted in the brain of the        recipient.    -   66. The connection assembly of any of statements 61-65, further        comprising a first connector for connecting the microcatheter to        the manifold, the first connector comprising: a hollow first        outer member having a first inner portion, a proximal end wall,        and an opening in the proximal end wall; a first sealing member        having a first inner channel configured to receive the proximal        end portion of the microcatheter, the first sealing member being        configured to be positioned in the first inner portion of the        first outer member; and a first pressing member configured to        press the first sealing member to compress the first sealing        member around the proximal end portion of the microcatheter when        the proximal end portion of the microcatheter is positioned        through the first inner channel of the first sealing member.    -   67. The connection assembly of statement 66, wherein the first        sealing member is configured to seal the first inner portion of        the first outer member when pressed by the first pressing        member.    -   68. The connection assembly of statement 66 or 67, wherein an        inner diameter of the first inner channel of the first sealing        member is about equal to or less than an outer diameter of the        microcatheter.    -   69. The connection assembly of any of statements 66-68, wherein:        the first inner portion of the first outer member comprises a        distal inner portion and a proximal inner portion; the first        sealing member is configured to be positioned in the proximal        inner portion of the first outer member; and the first pressing        member is configured to be positioned in the distal inner        portion of the first outer member.    -   70. The connection assembly of statement 69, wherein: the distal        inner portion of the first outer member is threaded; and the        first pressing member comprises a retainer screw.    -   71. The connection assembly of any of statements 66-70, wherein:        the manifold comprises a first opening for connecting the        microcatheter; and the first outer member is secured in the        first opening.    -   72. The connection assembly of any of statements 66-71, further        comprising a second connector for connecting the source catheter        to the manifold, the second connector comprising: a hollow        second outer member having a second inner portion, a distal end        wall, and an opening in the distal end wall; a second sealing        member having a second inner channel configured to receive the        distal end portion of the source catheter, the second sealing        member being configured to be positioned in the second inner        portion of the second outer member; and a second pressing member        configured to press the second sealing member to compress the        second sealing member around the distal end portion of the        source catheter when the distal end portion of the source        catheter is positioned through the second inner channel of the        second sealing member.    -   73. The connection assembly of statement 72, wherein: the        manifold comprises a second opening for connecting the source        catheter; and the second outer member is secured in the second        opening.    -   74. The connection assembly of any of statements 61-73, further        comprising a cover configured to cover the base member and the        manifold.

In the preceding description, various illustrative embodiments have beendescribed with reference to the accompanying drawings. It will, however,be evident that various modifications and changes may be made thereto,and additional embodiments may be implemented, without departing fromthe scope of the invention as set forth in the claims that follow. Forexample, certain features of one embodiment described herein may becombined with or substituted for features of another embodimentdescribed herein. The description and drawings are accordingly to beregarded in an illustrative rather than a restrictive sense.

What is claimed is:
 1. A connection assembly for an implantable drugdelivery system, the connection assembly comprising: a base memberconfigured to be attached to a skull of a recipient, the base membercomprising: an access hole for accessing a burr hole in the skull of therecipient; and an outer guide channel that extends along an outside edgeof the base member; and a manifold configured to fluidically couple aproximal end portion of a microcatheter to a distal end portion of asource catheter; wherein the base member is configured to position themicrocatheter through the access hole and in the outer guide channelwhen a distal end portion of the microcatheter is implanted in a brainof the recipient.
 2. The connection assembly of claim 1, wherein themanifold is integrally formed with the base member.
 3. The connectionassembly of claim 1, wherein: the base member further comprises an innerguide channel that extends from the access hole to the outside edge ofthe base member; and the base member is further configured to positionthe microcatheter in the inner guide channel when the distal end portionof the microcatheter is implanted in the brain of the recipient.
 4. Theconnection assembly of claim 3, wherein the outer guide channel extendsfrom the inner guide channel to an opening to the manifold.
 5. Theconnection assembly of claim 1, further comprising a first connector forconnecting the microcatheter to the manifold, the first connectorcomprising: a hollow first outer member having a first inner portion, aproximal end wall, and an opening in the proximal end wall; a firstsealing member having a first inner channel configured to receive theproximal end portion of the microcatheter, the first sealing memberbeing configured to be positioned in the first inner portion of thefirst outer member; and a first pressing member configured to press thefirst sealing member to compress the first sealing member around theproximal end portion of the microcatheter when the proximal end portionof the microcatheter is positioned through the first inner channel ofthe first sealing member.
 6. The connection assembly of claim 5, whereinthe first sealing member is configured to seal the first inner portionof the first outer member when pressed by the first pressing member. 7.The connection assembly of claim 5, wherein: the first inner portion ofthe first outer member comprises a distal inner portion and a proximalinner portion; the first sealing member is configured to be positionedin the proximal inner portion of the first outer member; and the firstpressing member is configured to be positioned in the distal innerportion of the first outer member.
 8. The connection assembly of claim7, wherein: the distal inner portion of the first outer member isthreaded; and the first pressing member comprises a retainer screw. 9.The connection assembly of claim 5, wherein: the manifold comprises afirst opening for connecting the microcatheter; and the first outermember is secured in the first opening.
 10. The connection assembly ofclaim 5, further comprising a second connector for connecting the sourcecatheter to the manifold, the second connector comprising: a hollowsecond outer member having a second inner portion, a distal end wall,and an opening in the distal end wall; a second sealing member having asecond inner channel configured to receive the distal end portion of thesource catheter, the second sealing member being configured to bepositioned in the second inner portion of the second outer member; and asecond pressing member configured to press the second sealing member tocompress the second sealing member around the distal end portion of thesource catheter when the distal end portion of the source catheter ispositioned through the second inner channel of the second sealingmember.
 11. The connection assembly of claim 10, wherein: the manifoldcomprises a second opening for connecting the source catheter; and thesecond outer member is secured in the second opening.
 12. The connectionassembly of claim 1, further comprising a cover configured to cover thebase member and the manifold.
 13. A method comprising: attaching acranial port to a skull of a recipient, the cranial port comprising abase member and a manifold, the base member comprising: an access holefor accessing a burr hole in the skull of the recipient; and an outerguide channel that extends along an outside edge of the base member;implanting a distal end portion of a microcatheter at a target locationwithin the recipient, the distal end portion of the microcathetercomprising an elution opening for eluting a fluid to the targetlocation; positioning the microcatheter through the access hole and inthe outer guide channel; and connecting a proximal end portion of themicrocatheter to the manifold.
 14. The method of claim 13, wherein: thebase member further comprises an inner guide channel that extends fromthe access hole to the outside edge of the base member; and the methodfurther comprises positioning the microcatheter in the inner guidechannel.
 15. The method of claim 13, wherein connecting the proximal endportion of the microcatheter to the manifold comprises: positioning afirst sealing member in a first inner portion of a hollow first outermember, the first outer member having a proximal end wall and an openingin the proximal end wall; inserting the proximal end portion of themicrocatheter through a first inner channel of the first sealing memberand through the opening in the proximal end wall; and causing a firstpressing member to press the first sealing member to compress the firstsealing member around the proximal end portion of the microcatheter. 16.The method of claim 15, wherein: the first inner portion of the firstouter member comprises a distal inner portion and a proximal innerportion; the first sealing member is positioned in the proximal innerportion of the first outer member; and the causing the first pressingmember to press the first sealing member comprises positioning the firstpressing member in the distal inner portion of the first outer member.17. A drug delivery system implantable in a recipient, comprising: acranial port comprising: a base member configured to be attached to askull of the recipient and comprising: an access hole for accessing aburr hole in the skull of the recipient; and an outer guide channel thatextends along an outside edge of the base member; and a manifold; and amicrocatheter comprising: a proximal end portion configured to befluidically connected to the manifold; and a distal end portionconfigured to be implanted at a target location within the recipient andcomprising an elution opening configured to elute a fluid to the targetlocation; wherein the base member is configured to position themicrocatheter through the access hole and in the outer guide channelwhen the distal end portion of the microcatheter is implanted at thetarget location.
 18. The drug delivery system of claim 17, furthercomprising a source catheter comprising: a proximal end portionconfigured to be fluidically connected to a fluid source configured toprovide a fluid; and a distal end portion configured to be fluidicallyconnected to the manifold.
 19. The drug delivery system of claim 17,wherein the manifold is integrally formed with the base member.
 20. Thedrug delivery system of claim 17, wherein: the base member furthercomprises an inner guide channel that extends from the access hole tothe outside edge of the base member; and the base member is furtherconfigured to position the microcatheter in the inner guide channel whenthe distal end portion of the microcatheter is implanted at the targetlocation.